Article
Overexpression of bromodomain factor 3 in Trypanosoma cruzi (TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors.
The FEBS journal - 1 Jun 2016
Alonso Victoria Lucia, Ritagliati Carla, Cribb Pamela, Cricco Julia Alejandra, Serra Esteban Carlos
Abstract excerpt
The bromodomain is the only protein domain known to bind acetylated lysine. In the last few years many bromodomain inhibitors have been developed in order to treat diseases such as cancer caused by aberrant acetylation of lysine residues. We have previously characterized Trypanosoma cruzi bromodomain factor 3 (TcBDF3), a bromodomain with an atypical localization that binds acetylated α-tubulin. In the present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
